Psoriasis and dandruff are both fairly common scalp conditions and are often confused. Somewhere between 2 and 3 percent of the population has psoriasis, and about half of these people have scalp ...
Medically reviewed by Susan Bard, MD Key Takeaways Psoriasis causes thick patches of skin called plaques that are dry and ...
Scalp Psoriasis vs. Dandruff: What’s the Difference? This article was reviewed by Knox Beasley, MD. If you’re experiencing a flaking, itching scalp, you may do a quick self-diagnosis of dandruff. But ...
Dear Doctors: I recently developed very bad psoriasis, but only on my scalp. The itch is awful. I’m not interested in the medications advertised on TV because of the side effects. Can you recommend ...
If you’ve struggled with itchy, irritated skin, you’ve probably sought out various creams, lotions or ointments to treat it. But if you feel like you’ve tried everything and still suffer from dry and ...
Please provide your email address to receive an email when new articles are posted on . At week 16, 49.4% of the tildrakizumab group achieved clearance or near clearance of their scalp psoriasis vs. 7 ...
While each product featured is independently selected by our editors, we may include paid promotion. If you buy something through our links, we may earn commission. Read more about our Product Review ...
Plaque PsO is an immune-mediated disease resulting in the overproduction of skin cells, which causes inflamed, scaly plaques that may be itchy or painful. It is estimated that eight million Americans ...
Please provide your email address to receive an email when new articles are posted on . Patients taking deucravacitinib vs. placebo or apremilast had significantly better scalp psoriasis improvement.
Guselkumab demonstrated strong efficacy in treating moderate to severe scalp psoriasis, especially in individuals with skin of color, achieving nearly 70% complete scalp clearance by week 48. The ...
Dear Doctors: I recently developed very bad psoriasis, but only on my scalp. The itch is awful. I’m not interested in the medications advertised on TV because of the side effects. Can you recommend ...
In the VISIBLE trial, guselkumab led to significant and sustained improvements in scalp psoriasis severity and quality of life in patients with skin of color through 48 weeks. Researchers evaluated ...